ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial carcinoma: A gynecologic oncology group study
Gynecologic Oncology
◽
10.1016/j.ygyno.2010.11.027
◽
2011
◽
Vol 121
(1)
◽
pp. 118-121
◽
Cited By ~ 20
Author(s):
David L. Tait
◽
John A. Blessing
◽
James S. Hoffman
◽
Kathleen N. Moore
◽
Nick M. Spirtos
◽
...
Keyword(s):
Endometrial Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
Download Full-text
Related Documents
Cited By
References
Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: A Gynecologic Oncology Group study
Gynecologic Oncology
◽
10.1016/j.ygyno.2006.03.043
◽
2006
◽
Vol 103
(2)
◽
pp. 523-526
◽
Cited By ~ 30
Author(s):
Paula M. Fracasso
◽
John A. Blessing
◽
Kelly L. Molpus
◽
Lisa M. Adler
◽
Joel I. Sorosky
◽
...
Keyword(s):
Endometrial Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Second Line
◽
Oncology Group
◽
Oncology Group Study
◽
Second Line Chemotherapy
◽
Line Chemotherapy
Download Full-text
Phase II study of fulvestrant in recurrent/metastatic endometrial carcinoma: A Gynecologic Oncology Group Study
Gynecologic Oncology
◽
10.1016/j.ygyno.2010.10.015
◽
2011
◽
Vol 120
(2)
◽
pp. 185-188
◽
Cited By ~ 37
Author(s):
Allan L. Covens
◽
Virginia Filiaci
◽
Deborah Gersell
◽
Christopher V. Lutman
◽
Albert Bonebrake
◽
...
Keyword(s):
Endometrial Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
Download Full-text
Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study
Gynecologic Oncology
◽
10.1016/j.ygyno.2003.09.018
◽
2004
◽
Vol 92
(1)
◽
pp. 4-9
◽
Cited By ~ 128
Author(s):
C Whitney
Keyword(s):
Endometrial Carcinoma
◽
Phase Ii
◽
Medroxyprogesterone Acetate
◽
Phase Ii Study
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
Download Full-text
Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041)
Annals of Oncology
◽
10.1093/annonc/mdq401
◽
2011
◽
Vol 22
(3)
◽
pp. 636-642
◽
Cited By ~ 29
Author(s):
H. Nomura
◽
D. Aoki
◽
F. Takahashi
◽
N. Katsumata
◽
Y. Watanabe
◽
...
Keyword(s):
Endometrial Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
◽
Randomized Phase Ii
Download Full-text
Phase II study of fulvestrant in recurrent/metastatic endometrial carcinoma: A Gynecologic Oncology Group Study
Yearbook of Oncology
◽
10.1016/j.yonc.2011.08.028
◽
2011
◽
Vol 2011
◽
pp. 98-99
Author(s):
J.T. Thigpen
Keyword(s):
Endometrial Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
Download Full-text
Faculty Opinions recommendation of Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717969752.793471344
◽
2013
◽
Author(s):
David Kushner
◽
Ryan Spencer
Keyword(s):
Endometrial Carcinoma
◽
Phase Ii
◽
Phase Ii Trial
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
Download Full-text
Phase II Study of Ifosfamide and Mesna in Nonsquamous Carcinoma of the Cervix: A Gynecologic Oncology Group Study
Gynecologic Oncology
◽
10.1006/gyno.1993.1084
◽
1993
◽
Vol 49
(1)
◽
pp. 48-50
◽
Cited By ~ 25
Author(s):
Gregory P. Sutton
◽
John A. Blessing
◽
Philip J. DiSaia
◽
William P. McGuire
Keyword(s):
Phase Ii
◽
Phase Ii Study
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
Download Full-text
Dactinomycin in the Treatment of Recurrent or Persistent Endometrial Carcinoma: A Phase II Study of the Gynecologic Oncology Group
Gynecologic Oncology
◽
10.1006/gyno.1999.5652
◽
1999
◽
Vol 75
(3)
◽
pp. 473-475
◽
Cited By ~ 23
Author(s):
David H. Moore
◽
John A. Blessing
◽
Charles Dunton
◽
Richard E. Buller
◽
Gary C. Reid
Keyword(s):
Endometrial Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
Download Full-text
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study
Yearbook of Oncology
◽
10.1016/s1040-1741(10)79511-7
◽
2010
◽
Vol 2010
◽
pp. 73-74
Author(s):
J.T. Thigpen
Keyword(s):
Endometrial Carcinoma
◽
Phase Ii
◽
Phase Ii Trial
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Her2 Positive
◽
Oncology Group Study
Download Full-text
Phase II trial of liposomal doxorubicin at 40 mg/m2 every 4 weeks in endometrial carcinoma: A Gynecologic Oncology Group Study
Gynecologic Oncology
◽
10.1016/j.ygyno.2005.05.016
◽
2005
◽
Vol 98
(2)
◽
pp. 294-298
◽
Cited By ~ 27
Author(s):
Howard D. Homesley
◽
John A. Blessing
◽
Joel Sorosky
◽
Gary Reid
◽
Katherine Y. Look
Keyword(s):
Endometrial Carcinoma
◽
Phase Ii
◽
Liposomal Doxorubicin
◽
Phase Ii Trial
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close